89 related articles for article (PubMed ID: 22531512)
1. CYP 2D6 polymorphism: a predictor of susceptibility and response to chemoradiotherapy in head and neck cancer.
Shukla P; Gupta D; Pant MC; Parmar D
J Cancer Res Ther; 2012; 8(1):40-5. PubMed ID: 22531512
[TBL] [Abstract][Full Text] [Related]
2. Association and treatment response to capecitabine-based chemoradiotherapy with CYP2C9 polymorphism in head and neck cancer.
Paul S; Pant MC; Parmar D; Verma J
Indian J Cancer; 2011; 48(2):223-9. PubMed ID: 21768671
[TBL] [Abstract][Full Text] [Related]
3. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Yadav SS; Ruwali M; Pant MC; Shukla P; Singh RL; Parmar D
Mutat Res; 2010 Feb; 684(1-2):49-55. PubMed ID: 19954746
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
5. Association of functionally important polymorphisms in cytochrome P450s with squamous cell carcinoma of head and neck.
Ruwali M; Parmar D
Indian J Exp Biol; 2010 Jul; 48(7):651-65. PubMed ID: 20929050
[TBL] [Abstract][Full Text] [Related]
6. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D
Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
9. The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.
Ouerhani S; Marrakchi R; Bouhaha R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Bull Cancer; 2008 Feb; 95(2):E1-4. PubMed ID: 18304900
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
[TBL] [Abstract][Full Text] [Related]
12. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
13. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use.
Peters ES; McClean MD; Liu M; Eisen EA; Mueller N; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):476-82. PubMed ID: 15734975
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer.
Ruwali M; Singh M; Pant MC; Parmar D
Xenobiotica; 2011 Dec; 41(12):1122-30. PubMed ID: 21957883
[TBL] [Abstract][Full Text] [Related]
15. [GSTM1 gene polymorphism in patients with head and neck tumors].
Gronau S; König-Greger D; Rettinger G; Riechelmann H
Laryngorhinootologie; 2000 Jun; 79(6):341-4. PubMed ID: 10923314
[TBL] [Abstract][Full Text] [Related]
16. [Influence of genetic variation in the major histocompatibility complex on head and neck cancer susceptibility].
Matthias C; Jahnke V; Hajeer A; Ollier W; Fryer AA; Strange RC
Laryngorhinootologie; 2001 Oct; 80(10):595-600. PubMed ID: 11602932
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
19. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
20. Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer.
Sabitha K; Reddy MV; Jamil K
Cancer Epidemiol; 2010 Oct; 34(5):587-92. PubMed ID: 20887941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]